Fund raise

Northland Capital Partners has acted as Nomad and Sole Broker in a US$1,000,000 placing for Polarean Imaging (POLX.L). The net proceeds of the Placing will be used to further support the FDA Phase III clinical trials in the US and further support improvements to the Company’s polarisers.